A carregar...
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
OBJECTIVES: To evaluate efficacy and safety of combination therapy using certolizumab pegol (CZP) and methotrexate (MTX) as first-line treatment for MTX-naive, early rheumatoid arthritis (RA) with poor prognostic factors, compared with MTX alone. METHODS: MTX-naive, early RA patients with ≤12 months...
Na minha lista:
Publicado no: | Ann Rheum Dis |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BMJ Publishing Group
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4717398/ https://ncbi.nlm.nih.gov/pubmed/26139005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-207511 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|